scanX
Home
SMS Pharmaceuticals

SMS Pharmaceuticals

250.45
-4.00
(-1.57%)
Market Cap (₹ Cr.)
₹2,124
52 Week High
398.00
Book Value
₹63
52 Week Low
113.30
PE Ratio
35.80
PB Ratio
3.77
PE for Sector
37.14
PB for Sector
4.89
ROE
0.84 %
ROCE
12.75 %
Dividend Yield
0.16 %
EPS
₹6.73
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
35.44 %
Net Income Growth
1,166.70 %
Cash Flow Change
123.25 %
ROE
987.67 %
ROCE
208.01 %
EBITDA Margin (Avg.)
50.53 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
164
125
153
157
173
93
133
126
94
130
128
104
102
125
136
102
104
118
118
81
100
114
131
150
173
164
176
123
61
65
160
151
151
136
167
163
247
166
198
Expenses
130
106
130
130
147
77
110
105
78
110
107
79
74
101
110
76
88
94
96
60
82
91
106
114
130
119
128
94
65
65
146
131
126
109
139
133
212
131
165
EBITDA
33
18
23
27
25
15
23
21
16
21
22
25
28
24
27
26
16
24
23
21
18
22
25
35
42
46
48
29
-4
0
14
20
25
27
29
30
35
35
33
Operating Profit %
11 %
6 %
8 %
9 %
6 %
16 %
17 %
17 %
17 %
16 %
16 %
24 %
26 %
19 %
19 %
25 %
15 %
20 %
19 %
25 %
15 %
19 %
18 %
23 %
24 %
27 %
27 %
23 %
-7 %
-1 %
9 %
12 %
16 %
20 %
17 %
18 %
14 %
20 %
16 %
Depreciation
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
5
6
6
6
8
8
8
8
8
8
8
8
8
8
8
8
8
9
Interest
5
4
4
4
5
4
4
4
3
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
5
5
5
4
5
5
6
6
6
6
6
6
5
5
Profit Before Tax
24
9
14
18
15
6
15
12
8
12
13
16
19
16
19
19
8
15
14
13
9
14
16
27
34
33
36
17
-16
-12
1
6
11
13
15
16
22
22
20
Tax
13
2
3
7
3
2
3
1
3
3
3
4
4
4
5
5
1
3
3
3
-0
3
3
5
6
7
8
4
-3
0
0
-0
0
3
3
4
5
5
5
Net Profit
10
7
10
11
13
4
9
10
12
9
9
12
10
10
13
12
6
9
10
8
6
9
11
18
22
23
25
11
9
-10
1
5
8
9
12
12
16
16
14
EPS in ₹
12.22
8.50
12.39
1.30
1.53
0.50
1.10
1.14
1.47
1.09
1.11
1.43
1.15
1.19
1.48
1.44
0.76
1.12
1.13
0.89
0.74
1.09
1.33
2.16
2.62
2.74
2.99
1.24
1.07
-1.16
0.09
0.59
0.95
1.10
1.42
1.44
1.88
1.93
1.68
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
540
656
501
519
577
627
830
883
914
1,068
Fixed Assets
277
370
290
279
281
280
457
438
412
437
Current Assets
202
248
157
168
208
219
309
377
411
534
Capital Work in Progress
29
13
8
8
18
42
7
11
33
30
Investments
0
0
37
45
45
45
45
45
45
45
Other Assets
234
273
166
187
232
259
321
389
424
556
Total Liabilities
286
362
238
218
237
260
402
389
419
498
Current Liabilities
165
200
147
121
143
145
195
196
255
332
Non Current Liabilities
120
162
91
97
94
114
206
193
164
166
Total Equity
255
294
263
301
340
367
428
494
495
570
Reserve & Surplus
246
286
254
293
331
359
420
485
487
562
Share Capital
8
8
8
8
8
8
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
9
1
0
2
-5
31
6
-39
29
Investing Activities
-55
-79
-39
-17
-35
-43
-152
-27
-30
-52
Operating Activities
59
61
73
32
50
40
90
45
22
50
Financing Activities
-10
27
-33
-15
-13
-2
92
-12
-32
31
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
67.29 %
67.29 %
67.29 %
67.29 %
67.29 %
64.17 %
64.17 %
64.17 %
64.29 %
64.32 %
64.32 %
64.32 %
64.67 %
64.67 %
64.67 %
FIIs
0.56 %
0.91 %
0.94 %
0.65 %
0.61 %
0.63 %
0.59 %
0.59 %
0.59 %
0.67 %
0.60 %
0.59 %
0.17 %
0.17 %
0.52 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.98 %
2.13 %
2.55 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.15 %
31.79 %
31.76 %
32.06 %
32.10 %
35.20 %
35.23 %
35.23 %
35.12 %
35.01 %
35.08 %
35.09 %
33.17 %
33.03 %
32.26 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,774.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Divis Laboratories
5,886.70 1,56,524.27 85.25 8,184.00 0.89 1,600 46.55 56.39
Cipla
1,470.00 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,567.05 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,213.40 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
947.95 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,029.55 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,246.00 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,534.00 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,491.30 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08

Corporate Action

Technical Indicators

RSI(14)
Neutral
27.62
ATR(14)
Less Volatile
14.96
STOCH(9,6)
Oversold
8.36
STOCH RSI(14)
Oversold
4.01
MACD(12,26)
Bearish
-3.46
ADX(14)
Strong Trend
34.80
UO(9)
Bullish
29.01
ROC(12)
Downtrend And Accelerating
-14.42
WillR(14)
Oversold
-96.39
Bearish
3
Neutral
2
Bullish
4
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.